LAVA Therapeutics Ownership 2024 | Who Owns LAVA Therapeutics Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

3.29%

Insider Ownership

28.72%

Retail Ownership

67.99%

Institutional Holders

10.00

LAVA Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
REDMILE GROUP, LLC7.75%0.25%2,074,372--6,907,659Mar 31, 2024
BRUCE & CO., INC.2.88%0.85%771,874--2,570,340Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.1.37%0.17%367,582367,582100.00%1,224,048Mar 31, 2024
WALLEYE CAPITAL LLC0.58%0.00%154,666154,666100.00%515,038Mar 31, 2024
ALPHA WAVE GLOBAL, LP0.40%0.11%107,906--359,327Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.31%0.00%82,03182,031100.00%273,163Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.0.24%0.00%65,000--216,450,000Mar 31, 2024
CITADEL ADVISORS LLC0.16%-43,20043,200100.00%143,856Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.07%-20,028-8,035-28.63%66,693Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.07%0.00%18,30018,300100.00%60,939Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.07%-17,70017,700100.00%58,941Mar 31, 2024
TWO SIGMA ADVISERS, LP0.06%0.00%16,70016,700100.00%55,611Mar 31, 2024
BANK OF AMERICA CORP /DE/0.06%-15,41115,411100.00%51,319,000Mar 31, 2024
PATHWAY FINANCIAL ADVISORS LLC0.05%0.01%14,00014,000100.00%46,620Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.05%0.00%12,90812,908100.00%42,984Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.04%-11,124--37,042Mar 31, 2024
MORGAN STANLEY0.04%-10,200-14,600-58.87%33,966Mar 31, 2024
CITADEL ADVISORS LLC0.04%-10,20010,200100.00%33,966Mar 31, 2024
UBS GROUP AG0.03%-8,9808,980100.00%29,903Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.02%-6,0006,000100.00%19,980,000Mar 31, 2024

LAVA Therapeutics's largest institutional shareholder is REDMILE GROUP, LLC, holding 7.75% of the company's total share outstanding, currently valued at $6.91M. The top 10 institutional shareholders own together 13.84% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BRUCE & CO., INC.2.88%0.85%771,874--2,570,340Mar 31, 2024
REDMILE GROUP, LLC7.75%0.25%2,074,372--6,907,659Mar 31, 2024
SPHERA FUNDS MANAGEMENT LTD.1.37%0.17%367,582367,582100.00%1,224,048Mar 31, 2024
ALPHA WAVE GLOBAL, LP0.40%0.11%107,906--359,327Mar 31, 2024
PATHWAY FINANCIAL ADVISORS LLC0.05%0.01%14,00014,000100.00%46,620Mar 31, 2024
CUTLER GROUP LLC / CA0.00%0.00%1,0001,000100.00%3,000Mar 31, 2024
WALLEYE CAPITAL LLC0.58%0.00%154,666154,666100.00%515,038Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.31%0.00%82,03182,031100.00%273,163Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.05%0.00%12,90812,908100.00%42,984Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.07%0.00%18,30018,300100.00%60,939Mar 31, 2024
TSFG, LLC0.00%0.00%400--1,000Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.0.24%0.00%65,000--216,450,000Mar 31, 2024
TWO SIGMA ADVISERS, LP0.06%0.00%16,70016,700100.00%55,611Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.02%-6,0006,000100.00%19,980,000Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.07%-20,028-8,035-28.63%66,693Mar 31, 2024
CITADEL ADVISORS LLC0.16%-43,20043,200100.00%143,856Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.07%-17,70017,700100.00%58,941Mar 31, 2024
UBS GROUP AG0.03%-8,9808,980100.00%29,903Mar 31, 2024
CITADEL ADVISORS LLC0.04%-10,20010,200100.00%33,966Mar 31, 2024
BANK OF AMERICA CORP /DE/0.06%-15,41115,411100.00%51,319,000Mar 31, 2024

The largest LAVA Therapeutics shareholder by % of total assets is BRUCE & CO., INC.. The company owns 771.87K shares of LAVA Therapeutics (LVTX), representing 0.85% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SPHERA FUNDS MANAGEMENT LTD.1.37%0.17%367,582367,582100.00%1,224,048Mar 31, 2024
WALLEYE CAPITAL LLC0.58%0.00%154,666154,666100.00%515,038Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.31%0.00%82,03182,031100.00%273,163Mar 31, 2024
CITADEL ADVISORS LLC0.16%-43,20043,200100.00%143,856Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.07%0.00%18,30018,300100.00%60,939Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.07%-17,70017,700100.00%58,941Mar 31, 2024
TWO SIGMA ADVISERS, LP0.06%0.00%16,70016,700100.00%55,611Mar 31, 2024
BANK OF AMERICA CORP /DE/0.06%-15,41115,411100.00%51,319,000Mar 31, 2024
PATHWAY FINANCIAL ADVISORS LLC0.05%0.01%14,00014,000100.00%46,620Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.05%0.00%12,90812,908100.00%42,984Mar 31, 2024
CITADEL ADVISORS LLC0.04%-10,20010,200100.00%33,966Mar 31, 2024
UBS GROUP AG0.03%-8,9808,980100.00%29,903Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.02%-6,0006,000100.00%19,980,000Mar 31, 2024
SIMPLEX TRADING, LLC0.01%-2,5892,589100.00%8,000Mar 31, 2024
CUTLER GROUP LLC / CA0.00%0.00%1,0001,000100.00%3,000Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.04%-11,124--37,042Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.0.24%0.00%65,000--216,450,000Mar 31, 2024
TSFG, LLC0.00%0.00%400--1,000Mar 31, 2024
ALPHA WAVE GLOBAL, LP0.40%0.11%107,906--359,327Mar 31, 2024
REDMILE GROUP, LLC7.75%0.25%2,074,372--6,907,659Mar 31, 2024

As of Mar 31 2024, LAVA Therapeutics's largest institutional buyer is SPHERA FUNDS MANAGEMENT LTD.. The company purchased 367.58K stocks of LVTX, valued at $1.22M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NOVO HOLDINGS A/S----1,878,194-100.00%-Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC----840,593-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----21,552-100.00%-Mar 31, 2024
MORGAN STANLEY0.04%-10,200-14,600-58.87%33,966Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----11,460-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.07%-20,028-8,035-28.63%66,693Mar 31, 2024
GROUP ONE TRADING, L.P.----100-100.00%-Mar 31, 2024
BRUCE & CO., INC.2.88%0.85%771,874--2,570,340Mar 31, 2024
REDMILE GROUP, LLC7.75%0.25%2,074,372--6,907,659Mar 31, 2024
ALPHA WAVE GLOBAL, LP0.40%0.11%107,906--359,327Mar 31, 2024
TSFG, LLC0.00%0.00%400--1,000Mar 31, 2024
PNC FINANCIAL SERVICES GROUP, INC.0.24%0.00%65,000--216,450,000Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.04%-11,124--37,042Mar 31, 2024
CUTLER GROUP LLC / CA0.00%0.00%1,0001,000100.00%3,000Mar 31, 2024
SIMPLEX TRADING, LLC0.01%-2,5892,589100.00%8,000Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.02%-6,0006,000100.00%19,980,000Mar 31, 2024
UBS GROUP AG0.03%-8,9808,980100.00%29,903Mar 31, 2024
CITADEL ADVISORS LLC0.04%-10,20010,200100.00%33,966Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.05%0.00%12,90812,908100.00%42,984Mar 31, 2024
PATHWAY FINANCIAL ADVISORS LLC0.05%0.01%14,00014,000100.00%46,620Mar 31, 2024

As of Mar 31 2024, LAVA Therapeutics's biggest institutional seller is NOVO HOLDINGS A/S. The company sold -1.88M shares of LVTX, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SPHERA FUNDS MANAGEMENT LTD.1.37%0.17%367,582367,582100.00%1,224,048Mar 31, 2024
WALLEYE CAPITAL LLC0.58%0.00%154,666154,666100.00%515,038Mar 31, 2024
TWO SIGMA INVESTMENTS, LP0.31%0.00%82,03182,031100.00%273,163Mar 31, 2024
CITADEL ADVISORS LLC0.16%-43,20043,200100.00%143,856Mar 31, 2024
SCHONFELD STRATEGIC ADVISORS LLC0.07%0.00%18,30018,300100.00%60,939Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.07%-17,70017,700100.00%58,941Mar 31, 2024
TWO SIGMA ADVISERS, LP0.06%0.00%16,70016,700100.00%55,611Mar 31, 2024
BANK OF AMERICA CORP /DE/0.06%-15,41115,411100.00%51,319,000Mar 31, 2024
PATHWAY FINANCIAL ADVISORS LLC0.05%0.01%14,00014,000100.00%46,620Mar 31, 2024
TWO SIGMA SECURITIES, LLC0.05%0.00%12,90812,908100.00%42,984Mar 31, 2024
CITADEL ADVISORS LLC0.04%-10,20010,200100.00%33,966Mar 31, 2024
UBS GROUP AG0.03%-8,9808,980100.00%29,903Mar 31, 2024
CIBC PRIVATE WEALTH GROUP, LLC0.02%-6,0006,000100.00%19,980,000Mar 31, 2024
SIMPLEX TRADING, LLC0.01%-2,5892,589100.00%8,000Mar 31, 2024
CUTLER GROUP LLC / CA0.00%0.00%1,0001,000100.00%3,000Mar 31, 2024

LAVA Therapeutics's largest new institutional shareholder by number of shares is SPHERA FUNDS MANAGEMENT LTD., purchased 367.58K shares, valued at $1.22M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NOVO HOLDINGS A/S----1,878,194-100.00%-Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC----840,593-100.00%-Mar 31, 2024
CITADEL ADVISORS LLC----21,552-100.00%-Mar 31, 2024
TOWER RESEARCH CAPITAL LLC (TRC)----11,460-100.00%-Mar 31, 2024
GROUP ONE TRADING, L.P.----100-100.00%-Mar 31, 2024

LAVA Therapeutics's largest sold out institutional shareholder by shares sold is NOVO HOLDINGS A/S, sold -1.88M shares, valued at -, as of undefined.

LAVA Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
BRUCE FUND INC0.37%771,874--Dec 31, 2023
Advisors' Inner Circle Fund III0.00%24,423--Jan 31, 2024

LAVA Therapeutics's largest mutual fund holder by % of total assets is "BRUCE FUND INC", owning 771.87K shares, compromising 0.37% of its total assets.

LAVA Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 2410-23.08%
31 Dec, 2313-
30 Sep, 2313-13.33%
30 Jun, 2315-21.05%
31 Mar, 2319-5.00%
31 Dec, 222066.67%
30 Sep, 2212-25.00%
30 Jun, 2216-
31 Mar, 2216-11.11%
31 Dec, 2118-
30 Sep, 2118-
30 Jun, 2118-25.00%
31 Mar, 2124-

As of 31 Mar 24, 10 institutions are holding LAVA Therapeutics's shares, representing a decrease of -23.08% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 24880,967-84.90%
31 Dec, 235,835,4382.05%
30 Sep, 235,718,284-0.49%
30 Jun, 235,746,405-14.73%
31 Mar, 236,739,420-10.46%
31 Dec, 227,526,9991.00%
30 Sep, 227,452,823-4.93%
30 Jun, 227,839,304-1.95%
31 Mar, 227,995,442-0.73%
31 Dec, 218,054,131-1.99%
30 Sep, 218,217,829-6.33%
30 Jun, 218,772,945-4.88%
31 Mar, 219,222,819-

LAVA Therapeutics (LVTX) has 880.97K shares outstanding as of 31 Mar 24, down -84.90% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 243.29%0.67%
31 Dec, 2322.20%4.69%
30 Sep, 2321.75%4.55%
30 Jun, 2321.86%3.33%
31 Mar, 2325.64%3.04%
31 Dec, 2229.03%3.49%
30 Sep, 2228.84%3.12%
30 Jun, 2230.41%3.16%
31 Mar, 2231.02%1.87%
31 Dec, 2140.76%4.01%
30 Sep, 2131.88%2.70%
30 Jun, 2134.37%2.63%
31 Mar, 2136.13%-

As of 31 Mar 24, LAVA Therapeutics is held by 3.29% institutional shareholders, representing a 0.67% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 246100.00%
31 Dec, 233200.00%
30 Sep, 231-87.50%
30 Jun, 23814.29%
31 Mar, 237-30.00%
31 Dec, 2210150.00%
30 Sep, 224100.00%
30 Jun, 222-33.33%
31 Mar, 223-25.00%
31 Dec, 214-42.86%
30 Sep, 217-12.50%
30 Jun, 218-66.67%
31 Mar, 2124-

6 institutional shareholders have increased their position in LVTX stock as of 31 Mar 24 compared to 3 in the previous quarter (a 100.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 24--100.00%
31 Dec, 234300.00%
30 Sep, 231-50.00%
30 Jun, 232-66.67%
31 Mar, 23650.00%
31 Dec, 224100.00%
30 Sep, 222-75.00%
30 Jun, 228100.00%
31 Mar, 224-33.33%
31 Dec, 216-
30 Sep, 216-14.29%
30 Jun, 217-
31 Mar, 21--

- institutional shareholders have reduced their position in LVTX stock as of 31 Mar 24 compared to 4 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 2410-23.08%880,967-84.90%3.29%0.67%6100.00%--100.00%
31 Dec, 2313-5,835,4382.05%22.20%4.69%3200.00%4300.00%
30 Sep, 2313-13.33%5,718,284-0.49%21.75%4.55%1-87.50%1-50.00%
30 Jun, 2315-21.05%5,746,405-14.73%21.86%3.33%814.29%2-66.67%
31 Mar, 2319-5.00%6,739,420-10.46%25.64%3.04%7-30.00%650.00%
31 Dec, 222066.67%7,526,9991.00%29.03%3.49%10150.00%4100.00%
30 Sep, 2212-25.00%7,452,823-4.93%28.84%3.12%4100.00%2-75.00%
30 Jun, 2216-7,839,304-1.95%30.41%3.16%2-33.33%8100.00%
31 Mar, 2216-11.11%7,995,442-0.73%31.02%1.87%3-25.00%4-33.33%
31 Dec, 2118-8,054,131-1.99%40.76%4.01%4-42.86%6-
30 Sep, 2118-8,217,829-6.33%31.88%2.70%7-12.50%6-14.29%
30 Jun, 2118-25.00%8,772,945-4.88%34.37%2.63%8-66.67%7-
31 Mar, 2124-9,222,819-36.13%-24---

LAVA Therapeutics Peer Ownership


TickerCompany
ANTXAN2 Therapeutics, Inc.
ANEBAnebulo Pharmaceuticals, Inc.
RZLTRezolute, Inc.
PMVPPMV Pharmaceuticals, Inc.
DSGNDesign Therapeutics, Inc.
GBIOGeneration Bio Co.
CCCCC4 Therapeutics, Inc.
TILInstil Bio, Inc.
ELYMEliem Therapeutics, Inc.
NXTCNextCure, Inc.
BNOXBionomics Limited
EWTXEdgewise Therapeutics, Inc.
AVTEAerovate Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
ERASErasca, Inc.
IKNAIkena Oncology, Inc.
ACHLAchilles Therapeutics plc
XLOXilio Therapeutics, Inc.
ADAGAdagene Inc.
NLTXNeurogene Inc.
ASMBAssembly Biosciences, Inc.
KRONKronos Bio, Inc.

LVTX Ownership FAQ


LAVA Therapeutics is owned by institutional shareholders (3.29%), insiders (28.72%), and public (67.99%). The largest institutional shareholder of LAVA Therapeutics is REDMILE GROUP, LLC (7.75% of total shares) and the top mutual fund owner is BRUCE FUND INC (0.37% of total shares).

LAVA Therapeutics's major institutional shareholders are REDMILE GROUP, LLC, BRUCE & CO., INC., SPHERA FUNDS MANAGEMENT LTD., WALLEYE CAPITAL LLC, and ALPHA WAVE GLOBAL, LP. The top five shareholders own together 12.99% of the company's share outstanding.

As of Mar 2024, there are 10 institutional shareholders of LAVA Therapeutics.

REDMILE GROUP, LLC owns 2.07M shares of LAVA Therapeutics, representing 7.75% of the company's total shares outstanding, valued at $6.91M (as of Mar 2024).

As of Mar 2024, BRUCE & CO., INC holds 771.87K shares of LAVA Therapeutics (LVTX), compromising 2.88% of the company, valued at $2.57M.

SPHERA FUNDS MANAGEMENT LTD is the third largest holder of LAVA Therapeutics. The company owns 367.58K of the company's shares outstanding (worth $1.22M).